An oral potassium channel blocker being developed to improve walking ability in people with multiple sclerosis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An oral potassium channel blocker being developed to improve walking ability in people with multiple sclerosis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.